Drug Shortage Report for SANDOZ DILTIAZEM CD
Report ID | 2699 |
Drug Identification Number | 02243340 |
Brand name | SANDOZ DILTIAZEM CD |
Common or Proper name | DILTIAZEM CD |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 240MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 100/BTL |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-03-14 |
Estimated end date | 2017-03-31 |
Actual end date | 2017-03-17 |
Shortage status | Resolved |
Updated date | 2017-03-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-03-21 | French | Compare |
v4 | 2017-03-21 | English | Compare |
v3 | 2017-03-15 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v1 | 2017-03-14 | English | Compare |
Showing 1 to 5 of 5